PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 2, 2025Frontiers in Reproductive Health2 citationsOpen Access

Effect of a luteal phase rescue protocol on live birth rates in frozen embryo transfer cycles

View Full Paper
CYChadi YazbeckFOF. OlivennesNKNadia Kazdar

Key Points

  • The rescue group exhibited a significantly higher live birth rate at 36.9%, compared to 24.7% in the control group, indicating a potential benefit of added progesterone.
  • Serum progesterone levels on the day before transfer were used to determine group assignments and guide treatment adjustments in this study analyzing 433 cycles.
  • Retrospective cohort analysis evaluated pregnancy outcomes including live birth, pregnancy rates, and miscarriage across patients with differing hormone levels.
  • The findings support tailoring hormone replacement therapy and progesterone administration protocols to enhance reproductive success during FET cycles.

Abstract

Introduction Frozen embryo transfer (FET) is a standard procedure that improves live birth rates and reduces ovarian hyperstimulation risks. Optimizing luteal phase support with hormone replacement therapy (HRT), particularly by progesterone supplementation, enhances endometrial receptivity and embryo implantation success. Despite advances in cryopreservation techniques, optimal protocols for progesterone supplementation in HRT-FET cycles remain uncertain. This study aims to evaluate the effects of an individualized luteal phase protocol using subcutaneous progesterone on live birth rates in HRT-FET cycles. Methods In this retrospective cohort study, we analyzed data from 433 autologous FET cycles prepared with HRT. Serum progesterone levels were measured the day before FET. Two groups were compared according to serum progesterone measurement the day before FET. The control group (≥ 11 ng/ml), received standard luteal support (800 mg vaginal progesterone daily); and the rescue group (11 ng/ml), received an additional 25 mg subcutaneous progesterone daily. Pregnancy outcomes, including biochemical pregnancy, clinical pregnancy, miscarriage, and live birth rates, were assessed across both groups. Results Despite overall similar pregnancy rates, the rescue group, receiving combined subcutaneous and vaginal progesterone, demonstrated a higher live birth rate compared to the control group (36.9% vs. 24.7%, p = 0.006). By Day 12 after FET, progesterone levels in the rescue group were comparable to those in the control group. Conclusion Our findings suggest that adding subcutaneous progesterone to standard vaginal support in HRT-FET cycles may improve reproductive outcomes in patients with low serum progesterone levels the day before transfer. These results support tailoring progesterone supplementation to optimize luteal phase support. Further controlled trials are needed to establish standardized protocols for HRT-FET cycles.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yazbeck et al. (2025) studied this question.

synapsesocial.com/papers/68de84b65b556a9128e1b53ahttps://doi.org/10.3389/frph.2025.1547939
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Individualized luteal phase support in frozen-thawed embryo transfer after intramuscular progesterone administration might rectify live birth rate2024 · 5 citations
  2. 2Endometriosis patients benefit from high serum progesterone in hormone replacement therapy–frozen embryo transfer cycles: a cohort study2022 · 23 citations
  3. 3Serum progesterone concentration on day of embryo transfer in donor oocyte cycles2014 · 92 citations
  4. 4Cumulative live birth rate after IVF: trend over time and the impact of blastocyst culture and vitrification2021 · 52 citations
  5. 5Pharmacokinetics and safety profile of a novel progesterone aqueous formulation administered by the s.c. route2012 · 63 citations